Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study

Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study

Bibliographic Details
Main Authors:	Batool Hossein Rashidi, Ensiyeh Shahrokh Tehrani, Firouzeh Ghaffari
Format:	Article
Language:	English
Published:	Elsevier 2014-12-01
Series:	Gynecologic Oncology Reports
Subjects:	Fertility preservation Cancer GnRH antagonist Controlled ovarian stimulation Random-start
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578914000307

Similar Items

OVARIAN STIMULATION FOR IVF-ET PROCEDURE
by: Robert Medved, et al.
Published: (2002-03-01)

Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
by: Tien K. Le, et al.
Published: (2024-03-01)

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome
by: Batool Hossein Rashidi, et al.
Published: (2015-10-01)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
by: Jamie Merkison, et al.
Published: (2022-09-01)

The Effect of Stimulation Protocols (GnRH Agonist vs. Antagonist) on the Activity of mTOR and Hippo Pathways of Ovarian Granulosa Cells and Its Potential Correlation with the Outcomes of In Vitro Fertilization: A Hypothesis
by: Michail Papapanou, et al.
Published: (2022-10-01)

Impact of different controlled ovarian stimulation protocols on the physical and psychological burdens in women undergoing in vitro fertilization/intra cytoplasmic sperm injection
by: Deenadayal Mamata, et al.
Published: (2015-01-01)

Ovarian Stimulation with FSH Alone versus FSH plus a GnRH Antagonist for Elective Freezing in an Oocyte Donor/Recipient Programme: A Protocol for a Pilot Multicenter Observational Study
by: Ioannis E. Messinis, et al.
Published: (2023-04-01)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
by: Depeng Zhao, et al.
Published: (2023-01-01)

Introduce an optimal method of ovarian stimulation in the polycystic ovarian syndrome affected: a randomized controlled trial
by: Azar Yahyaei, et al.
Published: (2023-06-01)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
by: Mu Lv, et al.
Published: (2022-10-01)

New Twists in Ovarian Stimulation and Their Practical Implications
by: Paul Pirtea, et al.
Published: (2019-09-01)

GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation
by: Georgios Valsamakis, et al.
Published: (2022-02-01)

Comparison of Controlled Ovarian Stimulation Protocols on IVF Outcome in Normal and Poor Responders
by: Deniz Esinler, et al.
Published: (2016-05-01)

Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation
by: Yu Li, et al.
Published: (2012-01-01)

Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study
by: Li-Hong Wei, et al.
Published: (2016-02-01)

Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve
by: Wanlin Zhang, et al.
Published: (2020-05-01)

Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial
by: Minoodokht Bavarsadkarimi, et al.
Published: (2022-07-01)

Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases
by: Jessica Daolio, et al.
Published: (2023-03-01)

Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis
by: Le Duc Thang, et al.
Published: (2024-04-01)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

The use of GnRH analogs in preserving ovarian function during chemotherapy
by: Omar M. Odeh, et al.
Published: (2021-11-01)

Fertility preservation in cancer patients
by: Dorothea Wunder, et al.
Published: (2012-09-01)

Cost-effectiveness of different types of COH protocols for in vitro fertilization at national level
by: Boriana Benbassat, et al.
Published: (2017-01-01)

Comparison of two different starting dose of rhFSH in GnRH antagonist protocol for patients with normal ovarian reserve
by: Zhi-cheng Jia, et al.
Published: (2023-01-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2016-05-01)

Intraindividual Embryo Morphokinetics Are Not Affected by a Switch of the Ovarian Stimulation Protocol Between GnRH Agonist vs. Antagonist Regimens in Consecutive Cycles
by: Jens E. Dietrich, et al.
Published: (2020-04-01)

GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus
by: Shahar Kol, et al.
Published: (2017-04-01)

Predictive factors of ovarian response to GnRH antagonist stimulation protocol: AMH and age are potential candidates
by: Mohammed M. Laqqan, et al.
Published: (2021-05-01)

Ovarian response determines the luteinizing hormone suppression threshold for patients following the gonadotrophin releasing hormone antagonist protocol: A retrospective cohort study
by: Qingfang Li, et al.
Published: (2024-01-01)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
by: Erkan Kalafat, et al.
Published: (2022-05-01)

Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles
by: Yao Lu, et al.
Published: (2021-03-01)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
by: Shen Zhao, et al.
Published: (2023-01-01)

Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With “Unpredictable” Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol
by: Chunhui Zhang, et al.
Published: (2021-10-01)

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
by: Fabrizio Fontana, et al.
Published: (2020-12-01)

A prediction model for high ovarian response in the GnRH antagonist protocol
by: Yilin Jiang, et al.
Published: (2023-11-01)

Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
by: Tzu-Ching Kao, et al.
Published: (2023-01-01)